The former Ethiopian Health Minister, Tedros Adhanom Ghebreyesus, will be the next director general of the World Health Organization (WHO). While he is well-liked by many, he certainly has his opponents–and for good reason.
Today health ministers and their entourages meet in Geneva at the World Health Assembly, where one of the primary topics discussed will be efforts to improve medicine quality.
This AEI Events Podcast features Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, discussing philanthropy, her background in medicine, an how the Gates Foundation is working to advance its motto that “all lives have equal value.”
Sue Desmond-Hellmann, CEO of the Bill and Melinda Gates Foundation, joins us for the first of three episodes for AEI’s Grand Opening Week.
AEI President Arthur Brooks hosts the Bill & Melinda Gates Foundation CEO Susan Desmond-Hellmann for a conversation on how private philanthropy can advance global public health.
Fake and substandard medicines are a significant problem in developing nations, and a growing problem in developed ones too. Our study finds that corruption is strongly correlated with poor quality drugs.
The current response to Zika eclipses the ever-present need to put in place a permanent infrastructure, capable of addressing the risks posed by mosquito-borne diseases.
We have aedes aegypti mosquitoes all over the US, especially in the South, so come spring we may a Zika outbreak here too.
Western officials should push to harmonize the definition of what constitutes “adulterated” medicine.
Citizens of the 21st century need to have a more comprehensive set of real-time metrics that are relevant to evolving health systems across the globe. One single ranking number is not going to tell us whether we are improving or not.